United States:
Episode 4: Exploring Recent Changes In Interoperability And Information Blocking (Video)
12 June 2021
McGuireWoods LLP
To print this article, all you need is to be registered or login on Mondaq.com.
For this episode of
Health+Tech, join
Lauren Riplinger, vice president of policy and government
affairs at AHIMA, and McGuireWoods
healthcare partner
Janice Suchyta, who co-leads the firm's digital health
group. Discussion will cover the following topics:
- The new Cures Act patient access rule and how to comply with
the open notes requirements
- Trends in health information interoperability among healthcare
entities
- Compliance needs for information-blocking rules and
exceptions
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
Healthcare Policy Developments To Watch In 2024
Crowell & Moring LLP
The ever-changing healthcare policy landscape will witness at the federal level regulatory changes driven by the need to transform healthcare delivery, quality and innovation.
The FDA And The Future Of AI Oversight
Manatt, Phelps & Phillips LLP
In January 2024, the U.S. Government Accountability Office (GAO) issued a report highlighting current obstacles to the U.S. Food and Drug Administration's (FDA) timely and effective regulation...